Related references
Note: Only part of the references are listed.Old drugs, new uses: Drug repurposing in hematological malignancies
Vijay P. Kale et al.
SEMINARS IN CANCER BIOLOGY (2021)
Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling
Xiaohong Zhang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2020)
Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug
Mandy Juarez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
The Cancer Stem Cell in Hepatocellular Carcinoma
Lucas-Alexander Schulte et al.
CANCERS (2020)
Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes
Na Li et al.
EPMA JOURNAL (2020)
Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection
Claudio Galvao de Castro Jr. et al.
LEUKEMIA & LYMPHOMA (2020)
Repurposing of drugs for triple negative breast cancer: an overview
Andrea Spini et al.
ECANCERMEDICALSCIENCE (2020)
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
Tian Tian et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-B pathway
Lu Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Anti-parasitic Drug Ivermectin Exhibits Potent Anticancer Activity Against Gemcitabine-resistant Cholangiocarcinoma In Vitro
Kitti Intuyod et al.
ANTICANCER RESEARCH (2019)
Isobologram Analysis: A Comprehensive Review of Methodology and Current Research
Ruo-yue Huang et al.
FRONTIERS IN PHARMACOLOGY (2019)
The PAK1-Stat3 Signaling Pathway Activates IL-6 Gene Transcription and Human Breast Cancer Stem Cell Formation
Ji-Hyang Kim et al.
CANCERS (2019)
Ivermectin induces autophagy-mediated cell death through the AKT/mTOR signaling pathway in glioma cells
Jingjing Liu et al.
BIOSCIENCE REPORTS (2019)
Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress
Jiaqiao Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage
Min Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress
Yingying Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers
Bo-Rim Yi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
Gan-Lu Deng et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Role of STAT3 in Cancer Metastasis and Translational Advances
Mohammad Zahid Kamran et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Practical efficacy of sorafenib monotherapy for advanced hepatocellular carcinoma patients in a Hepatitis B virus-endemic area
Ju Hyun Shim et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance
Jiangbing Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Share Paper
